Intuitive Surgical's stock price has fallen below its intrinsic value. Why do I think this presents a rare opportunity to grab ISRG stock? Click here to find out.
Global 2021 sales grew +18% year-over-year to €7.7M Regulatory News: Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio, the multidisciplinary probe and
Mauna Kea Technologies Reports Second Quarter and First Half of 2021 Sales finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Mauna Kea Technologies Reports Fourth Quarter and Full Year 2020 Sales
Full year sales decreased 12% year-over-year; U.S. sales up 4% year-over-year
2H 20 total sales up 27% year-over-year
Regulatory News:
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced sales results for the fourth quarter and twelve months of fiscal year 2020.
Fourth Quarter of 2020 Sales Summary
Total sales for the fourth quarter of 2020 increased €0.7 million, or 41% year-over-year, to €2.4 million
Consumables sales decreased €0.1 million, or 5% year-over-year, to €1.0 million
Systems sales increased €0.7 million, or 192% year-over-year, to €1.1 million
Services sales decreased 2% year-over-year to €0.3 million